Keynote Speaker: Local Persistence after Radiotherapy for Prostate Cancer: A Rationale for Dose Escalation to the Dominant Lesion

Abstract Archives of the RSNA, 2007

RO52-01

Keynote Speaker: Local Persistence after Radiotherapy for Prostate Cancer: A Rationale for Dose Escalation to the Dominant Lesion

Multisession Courses

Presented on November 29, 2007
Presented as part of RO52: BOOST: Prostate—Integrated Science and Practice Session (ISP)

Participants

Alan Pollack MD, PhD, Presenter: Grant, Varian Medical Systems, Inc Consultant, Calypso Medical Technologies, Inc

LEARNING OBJECTIVES

1. To understand the external beam radiation dose-response of prostate cancer. 2. To appreciate the frequency of local persistence after radiotherapy and the potential consequences. 3. To recognize the potential of image-guided targeting of the dominant intraprostatic tumor.

Cite This Abstract

Pollack, A, Keynote Speaker: Local Persistence after Radiotherapy for Prostate Cancer: A Rationale for Dose Escalation to the Dominant Lesion. Radiological Society of North America 2007 Scientific Assembly and Annual Meeting, November 25 - November 30, 2007 ,Chicago IL. http://archive.rsna.org/2007/6002289.html